Alexia Bakdache
Country Medical Director at Alnylam Pharmaceuticals | Greater Paris Metropolitan Region, France
Alexia Bakdache’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Alexia Bakdache serves as Country Medical Director for Alnylam Pharmaceuticals, managing medical affairs operations across the Greater Paris Metropolitan Region. A graduate of HEC Paris, she directs national clinical strategy and stakeholder engagement for the company’s RNA interference therapeutic portfolio. Her leadership supports a gene-silencing platform that successfully delivered the world’s first commercially approved RNAi medicine in 2018 following extensive foundational research.
BEST APPROACH TO REACH Alexia Bakdache
Reach out via LinkedIn connection requests featuring a concise summary of regional medical affairs value propositions, then transition the dialogue to her corporate work email for formal scheduling.
Country Medical Director at Alnylam Pharmaceuticals in September 2023 - Present
Medical Affairs Manager at Alnylam Pharmaceuticals in February 2022 - September 2023
Associate Director Marketing at Alnylam Pharmaceuticals in March 2020 - February 2022
Sr Brand Manager at Alnylam Pharmaceuticals in January 2019 - March 2020
Product Manager Advate & Adynovi - Hemophilia at Shire in June 2017 - December 2018
Product Manager on Elaprase - Hunter Disease at Shire in May 2015 - June 2017
Hospital Sales Representative -Rare Diseases at Shire in July 2016 - December 2016
Junior Product Manager - Immunology at MSD in November 2014 - April 2015
Junior Product Manager Remicade & Simponi - Gastroenterology at MSD in May 2014 - November 2014
Assistant Product Manager in PAH at Actelion (now Janssen Pulmonary Hypertension) in April 2013 - September 2013
HEC Paris, July 2026
Paris-Sud University (Paris XI), Pharmacy Doctor (PharmD), July 2026
SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email [email protected] or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861 Fraudulent Recruitment Activity Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."
Discover more about Alnylam Pharmaceuticals
Biotechnology & GMP
Manufacturing Associate at Alnylam Pharmaceuticals
(January 2025 – Present)
Regulatory Affairs Post-Doctoral Fellow at Alnylam Pharmaceuticals | 2024 SMDP Biotech Scholar
Pharmacy Intern at Spaulding Rehabilitation Hospital
(January 2022 – Present)
Manager, US Benefits at Alnylam Pharmaceuticals
Manager, US Benefits at Alnylam Pharmaceuticals
(December 2021 – Present)
Rare Disease Business Lead
Rare Disease Business Lead at Alnylam Pharmaceuticals
(September 2024 – Present)
Senior Director, Clinical Pharmacology and Pharmacometrics & Clinical Development Leader
Senior Director, Clinical Pharmacology and Pharmacometrics at Alnylam Pharmaceuticals
(December 2022 – Present)
Pharma & Biotech | Project Manager | Medical & Commercial Operations
Executive Assistant, Medical Affairs International & Global at Alnylam Pharmaceuticals
(November 2025 – Present)
What is Alexia Bakdache email address?
Email Alexia Bakdache at [email protected] and [email protected]. This email is the most updated Alexia Bakdache's email found in 2026.
How to contact Alexia Bakdache?
To contact Alexia Bakdache send an email to [email protected] or [email protected]. (updated on November 13, 2025)
What company does Alexia Bakdache work for?
Alexia Bakdache works for Alnylam Pharmaceuticals.
What is Alexia Bakdache's role at Alnylam Pharmaceuticals?
Alexia Bakdache is Country Medical Director
What industry does Alexia Bakdache work in?
Alexia Bakdache works in the Biotechnology industry.
